Lawless Labs Stenabol SR9009 Lawless Labs at a Glance
SR-9009 is a selective Rev-Erbα nuclear receptor agonist that modulates circadian rhythm gene expression and metabolic pathways in preclinical models. This compound demonstrates significant effects on mitochondrial biogenesis, lipid metabolism, and cellular energy expenditure when investigated in murine research models. SR-9009 functions as a metabolic modulator rather than a traditional SARM, targeting the Rev-Erbα receptor system to influence circadian biology and metabolic homeostasis.
Research Applications
Preclinical studies examine SR-9009 for metabolic syndrome research, circadian rhythm disruption models, and mitochondrial dysfunction investigations. Researchers at Stroid UK Shop frequently analyse this compound alongside other stenabolic research materials for comprehensive metabolic studies. Laboratory investigations demonstrate SR-9009’s capacity to modulate fatty acid oxidation pathways, enhance mitochondrial activity, and influence hepatic glucose production in controlled research environments. The compound’s unique mechanism makes it valuable for studying interactions between circadian clock disruption and metabolic disorders, complementing research conducted with traditional SARM compounds and peptide research materials.
Specification Data
| Parameter | Value |
|---|---|
| CAS Number | 1379686-30-2 |
| Molecular Formula | C₂₀H₂₄ClN₃O₄S |
| Molecular Weight | 437.94 g/mol |
| Classification | Rev-Erbα agonist |
| Storage Conditions | Room temperature, dry environment |
| Bioavailability | Limited oral bioavailability noted |
Research Compliance
This SR-9009 compound is supplied exclusively for in-vitro laboratory research purposes. Not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with all applicable regulations governing research chemical handling and disposal.
